Cargando…

Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review

Anti-NMDAR encephalitis has been associated with multiple antigenic triggers (i.e., ovarian teratomas, prodromal viral infections) but whether geographic, climatic, and environmental factors might influence disease risk has not been explored yet. We performed a systematic review and a meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alentorn, Agustí, Berzero, Giulia, Alexopoulos, Harry, Tzartos, John, Reyes Botero, Germán, Morales Martínez, Andrea, Muñiz-Castrillo, Sergio, Vogrig, Alberto, Joubert, Bastien, García Jiménez, Francisco A., Cabrera, Dagoberto, Tobon, José Vladimir, Delgado, Carolina, Sandoval, Patricio, Troncoso, Mónica, Galleguillos, Lorna, Giry, Marine, Benazra, Marion, Hernández Verdin, Isaias, Dade, Maëlle, Picard, Géraldine, Rogemond, Véronique, Weiss, Nicolas, Dalakas, Marinos C., Boëlle, Pierre-Yves, Delattre, Jean-Yves, Honnorat, Jérôme, Psimaras, Dimitri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295747/ https://www.ncbi.nlm.nih.gov/pubmed/37371620 http://dx.doi.org/10.3390/biomedicines11061525

Ejemplares similares

Neurological Syndromes Associated with Anti-GAD Antibodies
por: Dade, Maëlle, et al.
Publicado: (2020)

Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies
por: Dade, Maëlle, et al.
Publicado: (2021)

Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France
por: Hébert, Julien, et al.
Publicado: (2020)

Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies
por: Vialatte de Pémille, Clément, et al.
Publicado: (2018)

Neuroleptic intolerance in patients with anti-NMDAR encephalitis
por: Lejuste, Florian, et al.
Publicado: (2016)

Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis
por: Benoit, Jeanne, et al.
Publicado: (2022)

Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis
por: Muñiz-Castrillo, Sergio, et al.
Publicado: (2021)

Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies
por: Simard, Claire, et al.
Publicado: (2020)

Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin’s Lymphomas from Genome-Wide Association Studies
por: Hernández-Verdin, Isaias, et al.
Publicado: (2020)

CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis
por: Desestret, Virginie, et al.
Publicado: (2015)

Gut microbiome alterations in anti‐NMDA receptor encephalitis: caveats for result interpretation
por: Berzero, Giulia, et al.
Publicado: (2019)

Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2023)

Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies
por: Berzero, Giulia, et al.
Publicado: (2018)

Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features
por: Peter, Elise, et al.
Publicado: (2022)

Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis
por: Villagrán-García, Macarena, et al.
Publicado: (2023)

Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
por: Berzero, Giulia, et al.
Publicado: (2017)

Associations between HLA and autoimmune neurological diseases with autoantibodies
por: Muñiz-Castrillo, Sergio, et al.
Publicado: (2020)

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis
por: Joubert, Bastien, et al.
Publicado: (2017)

Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2022)

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2019)

Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations
por: Vogrig, Alberto, et al.
Publicado: (2023)

Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes
por: Déchelotte, Benoît, et al.
Publicado: (2020)

Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2020)

Prediction of Response to Temozolomide in Low‐Grade Glioma Patients Based on Tumor Size Dynamics and Genetic Characteristics
por: Mazzocco, P, et al.
Publicado: (2015)

Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies
por: Dalakas, Marinos C.
Publicado: (2018)

Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system
por: Dalakas, Marinos C.
Publicado: (2018)

Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost
por: Dalakas, Marinos C.
Publicado: (2017)

Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease: More to come with myositis in the offing
por: Dalakas, Marinos C.
Publicado: (2020)

Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications
por: Dalakas, Marinos C.
Publicado: (2020)

Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
por: Dalakas, Marinos C.
Publicado: (2021)

IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2021)

Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2022)

Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies
por: Dalakas, Marinos C.
Publicado: (2022)

Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology
por: Dalakas, Marinos C.
Publicado: (2023)

Objectivity, practicality, and significance of practice guidelines for the practicing neurologists: What we learnt from consensus criteria in CIDP, Myasthenia Gravis and Inflammatory Myopathies
por: Dalakas, Marinos C.
Publicado: (2023)

Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors
por: Terziev, Robert, et al.
Publicado: (2021)

Anti-LGI1 Encephalitis With Co-occurring IgLON5 Antibodies: Clinical Features and Human Leukocyte Antigen Haplotypes
por: Schiff, Pierre, et al.
Publicado: (2023)

Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases
por: Do, Le-Duy, et al.
Publicado: (2021)

Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors
por: Farina, Antonio, et al.
Publicado: (2022)

Autoimmune Neurogenic Dysphagia
por: Stathopoulos, Panos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_44gfbvfc5n8p20rjhsntd8ldcf